Training courses & Webinars:
Biopharma

Biopharmaceuticals, known colloquially as biopharma, are the point at which biotechnology and pharmaceutical manufacturing meet. Biopharma is the application of living organisms or extractions, by-products or components of living organisms, to prevent, relieve, or treat diseases.

Management Forum’s biopharma training courses provide an extensive series of training opportunities covering a variety of topics, including the development of biopharmaceuticals, clinical trial requirements, manufacture, regulations and applicable standards. Our courses also provide insight into the use of emerging technologies and state-of-the-art processes.  

 

Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

US FDA (Food and Drug Administration) - Understanding Key Factors When Working with the FDA (Food and Drug Administration) Training Course

US FDA - Understanding Key Factors When Working with the FDA

11 Jul 2025 - Online webinar
Also on: 26 Nov 2025

This course has been designed to provide an essential overview of the critical factors when working with the FDA (Food and Drug Administration).  For those short on time this course is for you, as you will receive a focused and comprehensive overview of the key strategic considerations when making applications to the FDA.  

Presented by Andrew Willis (bio)

More @ IPI Academy

In-house training

We can provide any of our courses on an in-house basis - at your location or online, with a programme and presenters tailored to your exact requirements. If you require training for multiple staff members, contact us to see how we can work with you.

Previous attendees said...

“
”

Thomas Lehmann Falck, , Novo Nordisk Denmark

“The Webinar gave me a lot of information around FDA [particularly] on general information/introduction to FDA Overall, [the speaker] was very good in explaining the topics and also in responding to the various questions. It was a useful webinar, and I would recommend it to others who aren't that familiar with the FDA/general legislation.”

Judith Handwerger, Manager Regulatory Affairs, Alfred E. Tiefenbacher (GmbH & Co. KG)